Literature DB >> 29675716

Disturbances of Sleep and Alertness in Parkinson's Disease.

Aleksandar Videnovic1,2,3.   

Abstract

PURPOSE OF REVIEW: Parkinson's disease (PD) is the second most common neurodegenerative disorder. Sleep dysfunction is one of the most common non-motor manifestations of PD that has gained significant interest over the past two decades due to its impact on the daily lives of PD patients, poorly understood mechanisms, and limited treatment options. In this review, we discuss the most common sleep disorders in PD and present recent investigations that have broadened our understanding of the epidemiology, clinical manifestations, diagnosis, and treatment of disturbed sleep and alertness in PD. RESENT
FINDINGS: The etiology of impaired sleep-wake cycles in PD is multifactorial. Sleep dysfunction in PD encompasses insomnia, REM sleep behavior disorder, sleep-disordered breathing, restless legs syndrome, and circadian dysregulation. Despite the high prevalence of sleep dysfunction in PD, evidence supporting the efficacy of treatment strategies is limited. We are at the opportune time to advance our understanding of sleep dysfunction in PD, which will hopefully lead to mechanisms-driven interventions for better sleep and allow us to approach sleep as a modifiable therapeutic target for other non-motor and motor manifestations in PD.

Entities:  

Keywords:  Excessive daytime sleepiness; Parkinson’s disease; REM sleep behavior disorder, circadian rhythm disorder; Sleep

Mesh:

Year:  2018        PMID: 29675716     DOI: 10.1007/s11910-018-0838-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  137 in total

1.  Increased risk of leg motor restlessness but not RLS in early Parkinson disease.

Authors:  M D Gjerstad; O B Tysnes; J P Larsen
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

2.  Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status.

Authors:  S-M Fereshtehnejad; M Shafieesabet; G A Shahidi; A Delbari; J Lökk
Journal:  Acta Neurol Scand       Date:  2014-09-28       Impact factor: 3.209

Review 3.  Management of sleep disorders in Parkinson's disease and multiple system atrophy.

Authors:  Aleksandar Videnovic
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

4.  Comparison of pregabalin with pramipexole for restless legs syndrome.

Authors:  Richard P Allen; Crystal Chen; Diego Garcia-Borreguero; Olli Polo; Sarah DuBrava; Jeffrey Miceli; Lloyd Knapp; John W Winkelman
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

5.  Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.

Authors:  William G Ondo; Thomas Perkins; Todd Swick; Keith L Hull; J Ernesto Jimenez; Tippy S Garris; Daniel Pardi
Journal:  Arch Neurol       Date:  2008-10

6.  Treatment outcomes in REM sleep behavior disorder.

Authors:  Stuart J McCarter; Christopher L Boswell; Erik K St Louis; Lucas G Dueffert; Nancy Slocumb; Bradley F Boeve; Michael H Silber; Eric J Olson; Maja Tippmann-Peikert
Journal:  Sleep Med       Date:  2013-01-23       Impact factor: 3.492

7.  Association between nocturnal/supine hypertension and restless legs syndrome in patients with Parkinson's disease.

Authors:  Yoon-Sang Oh; Joong-Seok Kim; In-Seok Park; In-Uk Song; Young-Min Son; Jeong-Wook Park; Dong-Won Yang; Hee-Tae Kim; Kwang-Soo Lee
Journal:  J Neurol Sci       Date:  2014-07-01       Impact factor: 3.181

8.  A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease.

Authors:  Marcello Moccia; Roberto Erro; Marina Picillo; Gabriella Santangelo; Emanuele Spina; Roberto Allocca; Katia Longo; Marianna Amboni; Raffaele Palladino; Roberta Assante; Sabina Pappatà; Maria Teresa Pellecchia; Paolo Barone; Carmine Vitale
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

9.  The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease.

Authors:  Daniel García-Lorenzo; Clarisse Longo-Dos Santos; Claire Ewenczyk; Smaranda Leu-Semenescu; Cecile Gallea; Graziella Quattrocchi; Patricia Pita Lobo; Cyril Poupon; Habib Benali; Isabelle Arnulf; Marie Vidailhet; Stéphane Lehericy
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

10.  Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.

Authors:  Alex Iranzo; Ana Fernández-Arcos; Eduard Tolosa; Mónica Serradell; José Luis Molinuevo; Francesc Valldeoriola; Ellen Gelpi; Isabel Vilaseca; Raquel Sánchez-Valle; Albert Lladó; Carles Gaig; Joan Santamaría
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more
  6 in total

Review 1.  Overview of Sleep and Circadian Rhythm Disorders in Parkinson Disease.

Authors:  Priti Gros; Aleksandar Videnovic
Journal:  Clin Geriatr Med       Date:  2019-09-06       Impact factor: 3.076

2.  A Computational Analysis in a Cohort of Parkinson's Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes.

Authors:  Müge Yalçin; Deeksha Malhan; Alireza Basti; Ana Rita Peralta; Joaquim J Ferreira; Angela Relógio
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 3.  Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease.

Authors:  Eiko N Minakawa
Journal:  Front Neurol       Date:  2022-07-18       Impact factor: 4.086

Review 4.  Excessive Daytime Sleepiness in Parkinson's Disease.

Authors:  Hanshu Liu; Jingwen Li; Xinyi Wang; Jinsha Huang; Tao Wang; Zhicheng Lin; Nian Xiong
Journal:  Nat Sci Sleep       Date:  2022-09-07

5.  Like a Wave in Its Variable Shape, Breadth, and Depth: A Qualitative Interview Study of Experiences of Daytime Sleepiness in People with Parkinson's Disease.

Authors:  Arja Höglund; Peter Hagell; Ulrika Östlund; Sten Fredrikson; Christina Sandlund
Journal:  Parkinsons Dis       Date:  2022-09-27

6.  Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.

Authors:  Aleksandar Videnovic; Amy W Amara; Cynthia Comella; Paula K Schweitzer; Helene Emsellem; Kris Liu; Amanda L Sterkel; Mildred D Gottwald; Joshua R Steinerman; Philip Jochelson; Katie Zomorodi; Robert A Hauser
Journal:  Mov Disord       Date:  2021-06-30       Impact factor: 10.338

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.